Literature DB >> 31062065

Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors.

Camila Cataldi1, Naiara Lourenço Mari1, Marcell Alysson Batisti Lozovoy2, Ligia Márcia Mário Martins3, Edna Maria Vissoci Reiche2, Michael Maes4,5, Isaias Dichi6, Andréa Name Colado Simão7.   

Abstract

OBJECTIVE: The objectives of this study were to delineate the pro and anti-inflammatory cytokine profiles of psoriasis and cytokine profile models that externally validate the diagnosis. SUBJECTS AND METHODS: This study recruited 70 patients with psoriasis and 76 healthy controls. Cytokine profiles were evaluated, including pro-inflammatory M1 (IL-1 + IL-6 + TNF-α), Th1 (IL-2 + IL-12 + IFN-γ), Th17 (IL-6 + IL-17), and immune-inflammatory response system (IRS = M1 + Th1 + Th17) profiles. Moreover, the anti-inflammatory potential included Th2 (IL-4), Th2 + T regulatory (Th2 + Treg, namely IL-4 + IL-10 + TGF-β), anti-inflammatory (Th2 + Treg + adiponectin), and the pro-inflammatory/anti-inflammatory index.
RESULTS: There was a highly significant association between psoriasis and cytokine levels with an effect size of 0.829 and a particularly strong impact on IL-2 (0.463), IL-12 (0.451), IL-10 (0.532) and adiponectin (0.401). TGF-β and adiponectin were significantly lower while all other cytokines (except IFN-γ) were significantly higher in psoriasis than in controls. In addition, M1, Th1, Th17, Th2 + Treg, and IRS/Anti-inflammatory index were significantly higher in psoriasis patients than in controls. The IRS index, Th2 + Treg, and adiponectin predicted psoriasis with 97.1% sensitivity and 94% specificity.
CONCLUSION: In conclusion, psoriasis is characterized by increased M1, Th1, Th2 and Th17 profiles together with lowered TGF-β and adiponectin. In addition, we propose a model based on a higher IRS and Th2 + Treg index coupled with lower adiponectin values, which may be used to externally validate the diagnosis of psoriasis. The most important single biomarker of psoriasis is adiponectin. Because the latter may play a role in the modulation of the chronic inflammatory response in psoriasis, adiponectin could be a new drug target to treat psoriasis.

Entities:  

Keywords:  Adiponectin; Cytokines; Inflammation; Psoriasis

Mesh:

Substances:

Year:  2019        PMID: 31062065     DOI: 10.1007/s00011-019-01238-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  49 in total

Review 1.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

2.  Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA.

Authors:  Mohamed F Elshal; J Philip McCoy
Journal:  Methods       Date:  2006-04       Impact factor: 3.608

Review 3.  A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage.

Authors:  Lawrence Steinman
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

4.  Serum and tissue expression of transforming growth factor beta 1 in psoriasis.

Authors:  H Zaher; O G Shaker; M H M EL-Komy; A El-Tawdi; M Fawzi; D Kadry
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-04       Impact factor: 6.166

5.  Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions.

Authors:  Iwona Flisiak; Bozena Chodynicka; Piotr Porebski; Robert Flisiak
Journal:  Cytokine       Date:  2002-08-07       Impact factor: 3.861

Review 6.  Genes and structure of selected cytokines involved in pathogenesis of psoriasis.

Authors:  Aldona Pietrzak; Anna Zalewska; Grazyna Chodorowska; Piotr Nockowski; Anna Michalak-Stoma; Paweł Osemlak; Dorota Krasowska
Journal:  Folia Histochem Cytobiol       Date:  2008       Impact factor: 1.698

Review 7.  A role for TGFbeta signaling in the pathogenesis of psoriasis.

Authors:  Gangwen Han; Cortny A Williams; Kelli Salter; Pamela J Garl; Allen G Li; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2009-08-27       Impact factor: 8.551

8.  Serum cytokines and growth factor levels in Japanese patients with psoriasis.

Authors:  H Takahashi; H Tsuji; Y Hashimoto; A Ishida-Yamamoto; H Iizuka
Journal:  Clin Exp Dermatol       Date:  2009-10-19       Impact factor: 3.470

Review 9.  Adiponectin and inflammation: consensus and controversy.

Authors:  Giamila Fantuzzi
Journal:  J Allergy Clin Immunol       Date:  2007-12-03       Impact factor: 10.793

10.  Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris.

Authors:  Hisao Doi; Masa-Aki Shibata; Kimihiro Kiyokane; Yoshinori Otsuki
Journal:  J Dermatol Sci       Date:  2003-10       Impact factor: 4.563

View more
  13 in total

1.  Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis.

Authors:  Guilherme Gomes Teixeira; Naiara Lourenço Mari; Jaqueline Costa Castardo de Paula; Camila Cataldi de Alcantara; Tamires Flauzino; Marcell Alysson Batisti Lozovoy; Ligia Márcia Mário Martin; Edna Maria Vissoci Reiche; Michael Maes; Isaias Dichi; Andréa Name Colado Simão
Journal:  Clin Exp Med       Date:  2019-11-22       Impact factor: 3.984

Review 2.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

Review 3.  Neutrophils in Psoriasis.

Authors:  Chih-Chao Chiang; Wei-Jen Cheng; Michal Korinek; Cheng-Yu Lin; Tsong-Long Hwang
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

4.  TGF-β1 Gene Polymorphism and Its Correlation with Serum Level of TGF-β1 in Psoriasis Vulgaris Among Iraqi People.

Authors:  Bryar T Ahmed; Mohammad Y Saeed; Saman H Noori; Dashty M Amin
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-11-24

5.  Effect of Very-Low-Calorie Ketogenic Diet on Psoriasis Patients: A Nuclear Magnetic Resonance-Based Metabolomic Study.

Authors:  Giuseppe Castaldo; Imma Pagano; Manuela Grimaldi; Carmen Marino; Paola Molettieri; Angelo Santoro; Ilaria Stillitano; Rocco Romano; Paola Montoro; Anna Maria D'Ursi; Luca Rastrelli
Journal:  J Proteome Res       Date:  2020-11-09       Impact factor: 4.466

6.  Analysis of the influence of adalimumab to the expression pattern of mRNA and protein of TGF-β1-3 in dermal fibroblast exposed to lipopolysaccharide.

Authors:  Michał Schweizer; Iwona Adwent; Beniamin O Grabarek; Dariusz Boroń
Journal:  Postepy Dermatol Alergol       Date:  2020-04-06       Impact factor: 1.837

7.  Comparison of mean platelet volume (MPV) and red blood cell distribution width (RDW) between psoriasis patients and controls: A systematic review and meta-analysis.

Authors:  Ping Yi; Jiao Jiang; Zheyu Wang; Xing Wang; Mingming Zhao; Haijing Wu; Yan Ding
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

Review 8.  Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.

Authors:  Maria J E Visser; Gareth Tarr; Etheresia Pretorius
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

9.  The Effect of Janus Kinase Inhibitors and Phosphodiesterase-4 Inhibitors on Skin and Plasma Cytokine Levels in Patients with Psoriasis.

Authors:  O G Artamonova; A E Karamova; A A Nikonorov; D A Verbenko; E L Vasileva; A A Kubanov
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804

Review 10.  Adiponectin in psoriasis and its comorbidities: a review.

Authors:  Bai Ruiyang; Fu Siqi; Adriana Panayi; Wu Ruifang; Zhang Peng
Journal:  Lipids Health Dis       Date:  2021-08-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.